Selenium speciation in paired serum and cerebrospinal fluid samples
- 623 Downloads
Se speciation was performed in 24 individual paired serum and cerebrospinal fluid (CSF) samples from neurologically healthy persons. Strong anion exchange (SAX) separation, coupled to inductively coupled plasma–dynamic reaction cell–mass spectrometry (ICP-DRC-MS), was employed. Species identification was done by standard matched retention time, standard addition and by size exclusion chromatography followed from SAX (2-D SEC-SAX-ICP-DRC-MS) and by SAX followed from CE-ICP-DRC-MS (2-D SAX-CE-ICP-DRC-MS). Limit of detection (LoD, 3 × standard deviation (SD) of noise) was in the range of 0.026–0.031 μg/L for all investigated species and thus was set uniformly to 0.032 μg/L. Quality control for total Se determination was performed by analysing control materials “human serum” and “urine”, where determined values met target values. Several Se species were found in both sample types having following median values (sequence: serum/CSF, each in μg Se/L): total Se, 58.39/0.86; selenoprotein P (SePP), 5.19/0.47; Se-methionine (SeM), 0.23/<LoD; glutathione peroxidase (GPx), 4.2/0.036; thioredoxinreductase (TrxR), 1.64/0.035; Se IV, 12.25/0.046; Se-human serum albumin (Se-HSA), 18.03/0.068. Other Se species, such as Se-cystine (SeC), Se VI and up to four non-identified compounds were monitored (if ever) only in very few samples usually close to LoD. Therefore, their median values were <LoD. Linear relationships based on median values provide information about Se-species passage across neural barriers (NB): SePP-serum is significantly correlated to total Se-serum when the latter was > 65 μg/L; however, SePP-CSF appeared independent of SePP-serum. For Se-HSA-serum versus (vs.) Se-HSA-CSF, a weak linear relationship was found (r 2 = 0.1722). On the contrary, for anti-oxidative Se-enzymes, higher r 2 values were calculated: GPx-serum vs. GPx-CSF, r 2 = 0.3837; TrxR-serum vs. TrxR-CSF, r 2 = 0.6293. Q -Se-species values (= ratios of CSF-Se-species/serum-Se-species) were compared with the Q -Alb value (HSA-CSF/HSA-serum = clinical index of NB integrity) for deeper information about NB passage of Se species. The Q -Se-HSA value (3.8 × 10−3) was in accordance to the molecular mass dependent restriction at NB (Q -Alb at 5.25 × 10−3). Increased Q values were seen for TrxR (21.3 × 10−3) and GPx (8.3 × 10−3) which are not (completely) explained by molecular size. For these two anti-oxidative Se-enzymes (GPx, TrxR), we hypothesize that there might be either a facilitated diffusion across NB or they might be additionally synthesized in the brain.
KeywordsSelenium speciation Cerebrospinal fluid Serum Thioredoxin reductase Glutathione peroxidase
The authors thank Katharina Fernsebner for reading the manuscript.
- 12.Aguilar V, Jimenez-Jimenez FJ, Molina JA, Meseguer I, Mateos-Vega CJ, Gonzales-Munoz MJ, de Bustos F, Gomez-Escalonilla C, Orti-Pareia M, Zurdo M, Martinez-Para MC (1998) Cerebrospinal fluid selenium and chromium levels in patients with Parkinson’s disease. J Neural Transm 105:1245–1251CrossRefGoogle Scholar
- 15.Siverling JM (2009) Master of Science in Analytical Chemistry, Cerebral Vasospasm post Subarachnoid Hemmorhage: an exploration of selenospecies and Se quantification in cerebrospinal fluid. Department of Chemistry of the College of Arts and Sciences, University of CincinnatiGoogle Scholar
- 24.Yan J, Barrett JN (1998) Purification from bovine serum of a survival-promoting factor for cultured central neurons and its identification as selenoprotein-P. J Neurosci 18(21):8682–8691Google Scholar
- 27.Eberle B, Haas HJ (1993) Purification of selenoprotein Ph from human plasma. J Trace Elem Electrolytes Health Dis 7(4):217–221Google Scholar
- 29.Reiber H, Thompson EJ, Grimsley G, Bernardi G, Adam P, Almeida SM, Fredman P, Keir G, Lammers M, Liblau R, Menna-Barreto M, Sá MJ, Seres E, Sindic CJM, Teelken A, Trendelenburg C, Trojano M, van Antwerpen MP, Verbeek MM (2003) Quality assurance for CSF protein analysis: international consensus by an internet-based group discussion. Clin Chem Lab Med 41:331–337CrossRefGoogle Scholar
- 30.Hühmer AF, Biringer RG, Amato H, Fonteh AN, Harrington MG (2006) Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and future challenges. Dis Markers 22(1–2):3–26Google Scholar